L
4.24
0.32 (8.16%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看跌 | 看跌 |
| Biotechnology (全球的) | 看跌 | 看跌 | |
| 股票 | Lexeo Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.0
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -1.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.00 |
|
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 0.75% |
| 机构持股比例 | 121.11% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| D1 Capital Partners L.P. | 31 Mar 2025 | 978,652 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 20.00 (Chardan Capital, 371.70%) | 购买 |
| 中 | 15.00 (253.77%) | |
| 低 | 10.00 (JP Morgan, 135.85%) | 购买 |
| 平均值 | 15.00 (253.77%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 2.93 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JP Morgan | 30 May 2025 | 10.00 (135.85%) | 购买 | 2.72 |
| HC Wainwright & Co. | 16 May 2025 | 15.00 (253.77%) | 购买 | 3.24 |
| 08 Apr 2025 | 23.00 (442.45%) | 购买 | 1.82 | |
| Chardan Capital | 13 May 2025 | 20.00 (371.70%) | 购买 | 2.83 |
| 08 Apr 2025 | 22.00 (418.87%) | 购买 | 1.82 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合